Guyasuta Investment Advisors Inc
Source: SEC Form 13F · as of Mar 2026Guyasuta Investment Advisors Inc holds 19 biotech & pharma companies tracked by BioSniper, totaling $79.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$79.6M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 103,368 | $25.3M |
| CORCencora Inc. | 58,038 | $18.2M |
| MRKMerck & Co., Inc. | 66,549 | $8.0M |
| ABBVAbbVie Inc. | 28,181 | $6.1M |
| PMPhilip Morris International Inc | 28,314 | $4.7M |
| PFEPFIZER INC | 120,517 | $3.4M |
| ABTABBOTT LABORATORIES | 27,453 | $2.8M |
| BMYBRISTOL MYERS SQUIBB CO | 46,066 | $2.8M |
| LLYELI LILLY & Co | 2,525 | $2.3M |
| NVSNovartis AG | 10,767 | $1.6M |
| AMGNAMGEN INC | 3,761 | $1.3M |
| GHGuardant Health Inc. | 7,000 | $647K |
| ZTSZoetis Inc. | 4,210 | $498K |
| WSTWest Pharmaceutical Services Inc. | 1,559 | $391K |
| ZBHZimmer Biomet Holdings Inc. | 4,071 | $368K |
| GEHCGE HealthCare Technologies Inc. | 4,411 | $314K |
| NVONovo Nordisk A/S | 8,537 | $314K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,666 | $258K |
| MCKMcKesson Corporation | 270 | $234K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.